By Counterforce Health Team in Crysvita (burosumab) —

How Long Does It Take to Get Crysvita (burosumab) Approved by Blue Cross Blue Shield of North Carolina? Complete Timeline & Appeals Guide

Answer Box: Fastest Path to Crysvita Coverage in North Carolina

Blue Cross Blue Shield of North Carolina typically takes 15 business days for standard Crysvita prior authorization, 72 hours for expedited review. Submit complete PA via Blue e portal with genetic confirmation (PHEX mutation), baseline labs (low serum phosphorus), and failed conventional therapy documentation. If denied, internal appeals take 15-30 days; external review through Smart NC takes 45 days (3 days expedited). Start today: call member services on your ID card to confirm PA requirements and specialty pharmacy network.

Table of Contents

What Affects Crysvita Approval Timing

Several factors influence how quickly Blue Cross Blue Shield of North Carolina processes your Crysvita (burosumab) prior authorization:

Benefit Type & Coverage Pathway

Crysvita is classified as a specialty drug under Blue Cross NC's medical benefit for office administration or specialty pharmacy benefit for home delivery. The specialty pharmacy network must be used for coverage, which can add coordination time if not arranged upfront.

Documentation Completeness

Complete submissions with genetic testing (PHEX mutation for XLH), baseline serum phosphorus levels, and detailed prior therapy history process fastest. Missing documentation triggers automatic delays for additional information requests.

Plan-Specific Requirements

Commercial, Medicare Advantage, and State Health Plan members have different PA pathways. Medical drug utilization management requirements vary by product line.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before submitting your PA, gather these required documents:

Clinical Records:

  • Confirmed XLH diagnosis with genetic testing (PHEX mutation) or biochemical evidence
  • Baseline labs: serum phosphorus, alkaline phosphatase, calcium, creatinine, 25-OH vitamin D, PTH
  • Prior therapy documentation: oral phosphate supplements and active vitamin D analogs (calcitriol, alfacalcidol)
  • Specialist evaluation from endocrinologist, nephrologist, or metabolic bone specialist

Insurance Verification:

  • Confirm member's specific Blue Cross NC plan type
  • Verify Crysvita coverage under medical vs. pharmacy benefit
  • Identify required specialty pharmacy network providers
Tip: Use Blue Cross NC's provider portal to run a real-time eligibility check and confirm PA requirements before gathering documentation.

Initial Review Process (1-15 Days)

Standard Review Timeline

Blue Cross NC allows up to 15 business days for standard specialty drug prior authorization decisions. The review process follows these stages:

  1. Administrative Review (1-2 days): Verification of member eligibility, provider credentials, and form completeness
  2. Clinical Review (3-10 days): Medical necessity assessment against Blue Cross NC's XLH criteria
  3. Final Determination (1-2 days): Approval letter or denial with specific reasons

Expedited Review Option

For urgent cases where delay could seriously jeopardize health, Blue Cross NC offers expedited review within 72 hours. Your prescriber must certify medical urgency and submit supporting documentation.

Expedited Review Criteria:

  • Progressive rickets with growth impairment
  • Severe bone pain affecting function
  • Risk of fractures or skeletal deformity
  • Contraindications to conventional therapy

Common Delays & How to Avoid Them

Documentation Gaps That Cause Delays

Missing Element Impact Solution
Genetic confirmation Automatic denial Include PHEX mutation report or FGF23 elevation with clinical evidence
Baseline phosphorus Review hold Provide recent labs showing hypophosphatemia
Prior therapy history Step therapy violation Document failed oral phosphate + vitamin D trials with doses, duration, outcomes
Specialist attestation Credentialing delay Ensure prescriber is board-certified endocrinologist/nephrologist

Additional Information Requests

If Blue Cross NC requests additional information, respond within 10 business days to avoid case closure. Common requests include:

  • Updated laboratory values
  • Clarification of diagnosis codes (ICD-10: E83.31 for familial hypophosphatemia)
  • Detailed treatment history with specific medication names and dosing

Decision Outcomes & Next Steps

Approval Scenarios

Full Approval: Typically granted for 6-12 months with specific dosing parameters and monitoring requirements. Approval letter includes:

  • Authorized dose and frequency
  • Required specialty pharmacy
  • Monitoring schedule (serum phosphorus every 4 weeks initially)

Conditional Approval: May require specific monitoring or dose limitations. Follow approval conditions exactly to maintain coverage.

Denial Reasons & Immediate Actions

Common Crysvita denials from Blue Cross NC include:

  • Insufficient genetic or biochemical evidence of XLH
  • Inadequate documentation of failed conventional therapy
  • Prescriber not meeting specialist requirements
  • Concurrent use of oral phosphate or active vitamin D

If denied, immediately:

  1. Request detailed denial letter
  2. Gather missing documentation identified in denial
  3. Consider internal appeal vs. corrected resubmission

Appeals Timeline & Process

Internal Appeals with Blue Cross NC

First-Level Appeal:

  • Deadline: 180 days from denial notice
  • Timeline: 15-30 days for decision (72 hours if expedited)
  • Submission: Via Blue e portal or provider services

Required Appeal Documentation:

  • Original denial letter
  • Additional clinical evidence addressing denial reasons
  • Updated medical necessity letter from specialist
  • Peer-reviewed literature supporting Crysvita use for XLH

External Review Through Smart NC

If internal appeals fail, North Carolina residents can request external review through Smart NC:

Timeline & Process:

  • Filing deadline: 120 days from final internal denial
  • Standard review: 45 days for binding decision
  • Expedited review: 3 calendar days for urgent cases
  • Cost: Free to consumers

Smart NC Contact:

Note: Smart NC staff provide free assistance with form completion and documentation gathering.

Renewal Cycles & Ongoing Coverage

Reauthorization Requirements

Blue Cross NC typically approves Crysvita for 6-12 month periods. Start renewal process 30-60 days before expiration to avoid treatment gaps.

Renewal Documentation:

  • Updated labs showing treatment response
  • Clinical progress notes
  • Continued medical necessity justification
  • Adherence and tolerability assessment

Factors That Speed Renewals

  • Documented improvement in serum phosphorus levels
  • Evidence of clinical benefit (reduced bone pain, improved growth in pediatric patients)
  • No serious adverse events
  • Continued specialist oversight

Timeline Visual Summary

Phase Standard Timeline Expedited Timeline Key Actions
Pre-submission 0-2 days Same Gather documentation, verify benefits
Initial review 1-15 business days 72 hours Submit complete PA via Blue e
Additional info 1-7 days if requested 24-48 hours Respond promptly to requests
Internal appeal 15-30 days 72 hours Submit enhanced documentation
External review 45 days 3 days File with Smart NC

Time-Saving Tips

For Healthcare Providers

  1. Use Blue e portal exclusively for fastest processing and real-time status tracking
  2. Submit complete packages initially to avoid back-and-forth requests
  3. Leverage specialty pharmacy partnerships for streamlined distribution
  4. Maintain template letters with Blue Cross NC-specific language and criteria

For Patients

  1. Call member services early to understand your specific plan requirements
  2. Coordinate with specialty pharmacy before PA submission
  3. Request expedited review when clinically appropriate
  4. Keep detailed records of all communications and deadlines
From our advocates: We've seen Crysvita approvals expedited significantly when families work closely with their endocrinologist to submit comprehensive genetic and biochemical evidence upfront, avoiding the common back-and-forth that can add weeks to the process.

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals that align with Blue Cross NC's specific requirements, significantly improving approval rates for complex specialty drugs like Crysvita.

FAQ

Q: How long does Blue Cross NC take for Crysvita prior authorization? A: Standard review takes up to 15 business days; expedited review is completed within 72 hours for urgent cases.

Q: What if Crysvita is denied by Blue Cross NC? A: You have 180 days to file an internal appeal, followed by external review through Smart NC within 120 days of final denial.

Q: Can I get expedited review for Crysvita? A: Yes, if your prescriber certifies that delay would seriously jeopardize your health or ability to regain function.

Q: Which specialty pharmacies can dispense Crysvita in North Carolina? A: Only Blue Cross NC network specialty pharmacies including Accredo, CVS Specialty, and others listed in their provider directory.

Q: What genetic testing is required for Crysvita approval? A: PHEX mutation confirmation for XLH or biochemical evidence including elevated FGF23 with hypophosphatemia.

Q: How often does Crysvita need reauthorization? A: Typically every 6-12 months with updated labs and clinical progress documentation.

Q: What happens if I need Crysvita urgently while waiting for approval? A: Request expedited review and consider manufacturer patient assistance programs for temporary supply during appeals.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and procedures change frequently. Always verify current requirements with Blue Cross Blue Shield of North Carolina and consult with qualified healthcare providers regarding medical decisions. For personalized assistance with complex prior authorizations and appeals, visit www.counterforcehealth.org.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.